Our results thus far identified that the development of glioblastoma is regulated by NF-κB through EZH2-dependent and independent pathway and led us to hypothesize that targeting of NF-κB can enhance the anti-cancer effects of EZH2 inhibition in glioblastoma. This evidence concerns the gene NFKB1 and glioblastoma.